Dartmouth-Hitchcock Health Begins Patient Treatments with ViewRay’s MRIdian Linac

ViewRay, Inc. (Nasdaq: VRAY) announced today that Dartmouth-Hitchcock Health in New Hampshire has begun patient treatments with the MRIdian^® MRI-Guided Therapy System, a cutting-edge radiation therapy device that combines the latest innovations in precision radiation delivery and ground-breaking MR-guidance. Dartmouth-Hitchcock Health is a non-profit academic health system primarily serving New Hampshire and Vermont as well as patients from across New England. As the largest health care system and employer in New Hampshire, Dartmouth-Hitchcock Health is committed to providing the highest quality of care to the nearly two million community members it serves. The addition of MRIdian brings cutting-edge MRI-guided radiation therapy closer to home for patients throughout the region and opens entirely new opportunities for research and clinical applications.

Kaohsiung Medical University Chung-Ho Memorial Hospital Begins Patient Treatments with ViewRay’s MRIdian Linac

ViewRay, Inc. announced today that Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH) in Kaohsiung City, Taiwan has begun patient treatments with the MRIdian® MR-Guided Radiation Therapy System, a cutting-edge device that delivers personalized cancer care by combining the latest innovations in precision radiation delivery with ground-breaking MR-guidance. The first two patients treated at KMUH on MRIdian were provided care for prostate cancer and tumor lesions in the left lung. Both treatments took advantage of MRIdian's automated beam-gating technology, protecting surrounding organs at risk.

Boston Globe COVID-19 Article Featuring MRIdian

“Cancer doesn’t wait,” said Dr. Daniel Cagney, a radiation oncologist. “Initially in March and April, there were significant unknowns, but we’ve been living with this for a few months. ... I feel very confident that we will provide the best care for patients and it’s safe for them to come into the hospital.”